Insider Stock Trading History of Byrnes Robert F


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Byrnes Robert F since year 2005. The trader's CIK number is 1263175. At the time of this reporting, Byrnes Robert F is the Director of Revance Therapeutics, Inc. . (stock ticker symbol RVNC). See this page for all insider trading activities at Revance Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Byrnes Robert F since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-02-12 RVNC Revance Therapeutics, Inc. Option Ex 10,999 3.90 42,896
2014-09-17 RVNC Revance Therapeutics, Inc. Option Ex 2,666 3.60 9,597

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Byrnes Robert F (Director of Revance Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.